ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981

Final Issue Of 1984

December 13, 1984

Preventive Services Task Force Urges Colorectal Cancer Screening for 50 and Up; Advises Against Tamoxifen for Women at Low to Average Breast Cancer Risk

July 19, 2002

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006